These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3373747)

  • 21. Prostaglandins for peptic ulcer: a promise unfulfilled.
    Hawkey CJ; Walt RP
    Lancet; 1986 Nov; 2(8515):1084-7. PubMed ID: 2877235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of action of new drugs in ulcer therapy].
    Simon B; Fromm T; Kather H; Kommerell B
    Verh Dtsch Ges Inn Med; 1978; (84):984-7. PubMed ID: 742166
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
    Sakai M
    Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Lauritsen K; Rask-Madsen J
    Arch Intern Med; 1990 Mar; 150(3):695. PubMed ID: 2310294
    [No Abstract]   [Full Text] [Related]  

  • 26. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wahlby L
    Scand J Gastroenterol Suppl; 1987; 140():39-47. PubMed ID: 3328284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy and prevention of peptic lesions by prostaglandins].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of in vivo and in vitro interactions of an aluminum hydroxide, magnesium hydroxide containing antacid with cimetidine in patients with peptic ulcer.
    Allgayer H; Röllinghoff W; Paumgartner G
    Z Gastroenterol; 1983 Jul; 21(7):351-4. PubMed ID: 6613216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sucralfate--alternative therapy for peptic-ulcer disease.
    Garnett WR
    Clin Pharm; 1982; 1(4):307-14. PubMed ID: 6764389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NSAID-induced mucosal injury.
    Liebowitz D
    J Clin Gastroenterol; 1988 Dec; 10(6):609-11. PubMed ID: 3230276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caved-S and Ulcedal for peptic ulcer.
    Drug Ther Bull; 1973 Feb; 11(3):10-2. PubMed ID: 4571693
    [No Abstract]   [Full Text] [Related]  

  • 35. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
    Fukuchi S
    Nihon Rinsho; 1988 Jan; 46(1):119-23. PubMed ID: 3373744
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective and therapeutic effects of gastrointestinal prostaglandins. Enprostil: a new modality. Proceedings of a symposium. November 13-14, 1985, Toronto, Canada.
    Am J Med; 1986 Aug; 81(2A):1-88. PubMed ID: 3092649
    [No Abstract]   [Full Text] [Related]  

  • 38. Are prostaglandins truly "cytoprotective"?
    Morris GP
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):326-30. PubMed ID: 3760515
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostaglandin analogues.
    Lauritsen K; Rask-Madsen J
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):621-8. PubMed ID: 3048453
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of sulpiride in the therapeutic strategy of severe gastro-duodenal ulcers in surgery].
    Leguyader A
    Med Chir Dig; 1976; 5(4):255-8. PubMed ID: 950827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.